# Absorb IV Randomized Controlled Trial

> **NCT02173379** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 2604 (actual)

## Conditions studied

- Coronary Artery Disease
- Coronary Artery Stenosis
- Coronary Disease
- Coronary Stenosis

## Interventions

- **DEVICE:** Absorb BVS
- **DEVICE:** XIENCE

## Key facts

- **NCT ID:** NCT02173379
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2022-04-06
- **Final completion:** 2022-04-06
- **Target enrollment:** 2604 (ACTUAL)
- **Last updated:** 2023-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02173379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02173379, "Absorb IV Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02173379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*